Advertisements



Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge

Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge.....»»

Category: topSource: seekingalphaNov 14th, 2017

Your Daily Pharma Scoop: Celgene"s CELMoD Potential, Allergan"s Senate Troubles, Abbott Approval Surge

Your Daily Pharma Scoop: Celgene"s CELMoD Potential, Allergan"s Senate Troubles, Abbott Approval Surge.....»»

Category: topSource: seekingalphaSep 28th, 2017

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study.....»»

Category: topSource: seekingalpha4 hr. 34 min. ago

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA Approvals, GW Pharmaceuticals" Price Target Lowered

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA Approvals, GW Pharmaceuticals" Price Target Lowered.....»»

Category: topSource: seekingalphaNov 15th, 2017

Your Daily Pharma Scoop: Regeneron"s Appeal, Good News For Amgen, Bristol-Myers" Sprycel

Your Daily Pharma Scoop: Regeneron"s Appeal, Good News For Amgen, Bristol-Myers" Sprycel.....»»

Category: topSource: seekingalphaNov 13th, 2017

Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars

Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars.....»»

Category: topSource: seekingalphaNov 12th, 2017

Your Daily Pharma Scoop: Portola Upside, Novartis Reports Positive Cosentyx Data, Keryx Tumbles

Your Daily Pharma Scoop: Portola Upside, Novartis Reports Positive Cosentyx Data, Keryx Tumbles.....»»

Category: topSource: seekingalphaNov 9th, 2017

Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst

Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst.....»»

Category: topSource: seekingalphaNov 6th, 2017

Your Daily Pharma Scoop: Gilead In NASH, Geron Gets A Boost, AstraZeneca"s Oncology Portfolio

Your Daily Pharma Scoop: Gilead In NASH, Geron Gets A Boost, AstraZeneca"s Oncology Portfolio.....»»

Category: topSource: seekingalphaNov 1st, 2017

Your Daily Pharma Scoop: Portola"s PDUFA, PDLI Makes Some Money, GWPH Completes Rolling NDA

Your Daily Pharma Scoop: Portola"s PDUFA, PDLI Makes Some Money, GWPH Completes Rolling NDA.....»»

Category: topSource: seekingalphaOct 31st, 2017

Your Daily Pharma Scoop: Celgene"s Big Fall, Tesaro VARUBI Approval, TGTX Midstage Success

Your Daily Pharma Scoop: Celgene"s Big Fall, Tesaro VARUBI Approval, TGTX Midstage Success.....»»

Category: topSource: seekingalphaOct 28th, 2017

Your Daily Pharma Scoop: Roche"s Investment Potential, Sarepta Lifts Guidance, Pfizer Restructuring

Your Daily Pharma Scoop: Roche"s Investment Potential, Sarepta Lifts Guidance, Pfizer Restructuring.....»»

Category: topSource: seekingalphaOct 26th, 2017

Your Daily Pharma Scoop: Soliris New Indication, Gilead"s NASH Data, What Keeps Synergy Down?

Your Daily Pharma Scoop: Soliris New Indication, Gilead"s NASH Data, What Keeps Synergy Down?.....»»

Category: topSource: seekingalphaOct 25th, 2017

Your Daily Pharma Scoop: Valeant Value Trap, Agenus Upside, Celgene"s Potential

Your Daily Pharma Scoop: Valeant Value Trap, Agenus Upside, Celgene"s Potential.....»»

Category: topSource: seekingalphaOct 24th, 2017

Your Daily Pharma Scoop: Adamis Upside Potential, J&J"s SIMPONI Label Expansion, SGEN"s Adcetris Upgrade And PDUFA

Your Daily Pharma Scoop: Adamis Upside Potential, J&J"s SIMPONI Label Expansion, SGEN"s Adcetris Upgrade And PDUFA.....»»

Category: topSource: seekingalphaOct 23rd, 2017

Your Daily Pharma Scoop: Johnson & Johnson"s Mixed Signals, Celgene"s Mongersen Failure, QURE"s Hemophilia B Trial

Your Daily Pharma Scoop: Johnson & Johnson"s Mixed Signals, Celgene"s Mongersen Failure, QURE"s Hemophilia B Trial.....»»

Category: topSource: seekingalphaOct 20th, 2017

Your Daily Pharma Scoop: Gilead"s Brave New World, AZN"s Lynparza SNDA, RXDX Entrectinib Shows Positive Results

Your Daily Pharma Scoop: Gilead"s Brave New World, AZN"s Lynparza SNDA, RXDX Entrectinib Shows Positive Results.....»»

Category: topSource: seekingalphaOct 19th, 2017

Your Daily Pharma Scoop: AZN"s Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?

Your Daily Pharma Scoop: AZN"s Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?.....»»

Category: topSource: seekingalphaOct 18th, 2017

Your Daily Pharma Scoop: Everybody"s Gilead Problem, Halozyme"s Further Progress, Ziopharm"s Gene Therapy

Your Daily Pharma Scoop: Everybody"s Gilead Problem, Halozyme"s Further Progress, Ziopharm"s Gene Therapy.....»»

Category: topSource: seekingalphaOct 17th, 2017

Your Daily Pharma Scoop: ACRX Second Chance, AERI Rhopressa Success, Aratana ENTYCE Launch

Your Daily Pharma Scoop: ACRX Second Chance, AERI Rhopressa Success, Aratana ENTYCE Launch.....»»

Category: topSource: seekingalphaOct 16th, 2017

Your Daily Pharma Scoop: AcelRx DSUVIA PDUFA, Ardelyx Phase 3 Success, Rhopressa, LUXTURNA Adcomm Tomorrow

Your Daily Pharma Scoop: AcelRx DSUVIA PDUFA, Ardelyx Phase 3 Success, Rhopressa, LUXTURNA Adcomm Tomorrow.....»»

Category: topSource: seekingalphaOct 12th, 2017